NUS Medicine researchers create AI-guided gene-editing tool for more precise and safer DNA correction
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-May-2026 11:16 ET (26-May-2026 15:16 GMT/UTC)
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary new method to improve compact gene-editing tools known as base editors, which enable smaller, more precise DNA correction tools that may be safer for future gene therapies.Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary new method to improve compact gene-editing tools known as base editors, which enable smaller, more precise DNA correction tools that may be safer for future gene therapies.
The introduction of vision-enabled artificial intelligence (AI) to medical scribes – the recording devices used by doctors to document meetings with patients in real-time – could increase the accuracy of patient notes and save valuable time for clinicians.Researchers found that a vision-enabled AI scribe, employing a combination of Google’s Gemini model and Ray-Ban Meta smart glasses, substantially improved the documentation accuracy of pharmacist-patient consultations and reduced omissions and errors in clinical notes.
The Gilead Australia Medical Fellowships, now in their 15th year, support Australian-led clinical research to improve patient care, awarding over $4 million to projects in HIV, chronic viral hepatitis, and hematological malignancies. Applications for the 2027 Fellowships are open until 05/14/2026, with recipients announced in July. For details, visit the Gilead Sciences Australia website. https://www.gilead.com.au/our-purpose/corporate-giving/gilead-australia-fellowship
UCLA Health will host its first-ever Brain Health Summit on March 20-21, bringing together leading scientists, policymakers, philanthropists and community advocates from across the country to address one of the most pressing and underfunded challenges in public health.
Northwestern Medicine scientists have discovered that specialized immune cells within the glioblastoma tumor metabolize fructose to suppress immune responses and promote tumor growth, reports a study published on March 17 in the Proceedings of the National Academy of Sciences.
The study, the first to identify this sugar pathway as a driver of immune suppression in brain tumors, suggests that blocking fructose metabolism in the specialized cells may improve immunotherapy response and patient outcomes.